Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.930
-0.150 (-4.87%)
At close: Jun 5, 2026, 4:00 PM EDT
3.120
+0.190 (6.48%)
After-hours: Jun 5, 2026, 5:14 PM EDT
Genelux Revenue
Genelux had revenue of $8.00K in the twelve months ending March 31, 2026. In the year 2025, Genelux had annual revenue of $8.00K.
Revenue (ttm)
$8.00K
Revenue Growth
n/a
P/S Ratio
16,264.76
Revenue / Employee
$308
Employees
26
Market Cap
130.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.00K | - | - |
| Dec 31, 2024 | 8.00K | -162.00K | -95.29% |
| Dec 31, 2023 | 170.00K | -10.90M | -98.46% |
| Dec 31, 2022 | 11.07M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 123.87M |
| Black Diamond Therapeutics | 70.00M |
| Alpha Cognition | 10.83M |
| Kazia Therapeutics | 1.27M |
| Spruce Biosciences | 697.00K |
| Connect Biopharma Holdings | 233.00K |
| Fractyl Health | 3.00K |
GNLX News
- 4 weeks ago - Genelux reports Q1 EPS (20c), consensus (19c) - TheFly
- 4 weeks ago - Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates - GlobeNewsWire
- 4 weeks ago - Genelux Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Genelux Earnings release: Q1 2026 - Filings
- 4 weeks ago - Genelux Slides: Corporate presentation - Filings
- 5 weeks ago - Genelux Proxy statement: Proxy filing - Filings
- 5 weeks ago - Genelux Proxy statement: Proxy filing - Filings
- 2 months ago - Genelux price target lowered to $20 from $23 at Benchmark - TheFly